An update in recurrent spontaneous abortion

被引:251
作者
Pandey M.K. [1 ]
Rani R. [2 ]
Agrawal S. [3 ]
机构
[1] Division of Molecular Immunology, Cincinnati Children's Hospital Medical Center, MLC 7021 TCH RF 5503, Cincinnati, OH 45229-3039
[2] Department of Biology, University of Texas, San Antonio, TX
[3] Department of Medical Genetics, SGPGIMS, Lucknow
关键词
1α; 25 -Dihydroxy-vitamin-D3 (VD3) therapy; ANA (anti-nuclear antibody); APA (anti-phospho lipid antibody); Aspirin/Heparin therapy; Immunoglobulin (IVIg) therapy; Lymphocyte immunotherapy; RSA (Recurrent spontaneous abortion);
D O I
10.1007/s00404-004-0706-y
中图分类号
学科分类号
摘要
Recurrent spontaneous abortion (RSA) is defined as three or more consecutive pregnancy losses prior to the 20th week of gestation. The etiology of recurrent spontaneous abortion is often unclear and may be multifactorial, with much controversy regarding diagnosis and treatment. Reasonably accepted etiologic causes include, genetics, anatomical, endocrine, placental anomalies, hormonal problems, infection, smoking and alcohol consumption, exposure to environmental factors, psychological trauma and stressful life event, certain coagulation and immunoregulatory protein defects. Detection of an abnormality in any of these areas may result into specific therapeutic measures, with varying degrees of success. However, the majority of cases of RSA remains unexplained and is found to be associated with certain autoimmune (APA, ANA, ACA, ATA, AECA) and alloimmune (APCA, Ab2, MLR-Bf) antibodies that may play major role in the immunologic failure of pregnancy and may lead to abortion. Alteration in the expression of HLA-G molecules, T-helper-1 (Th-1) pattern of cytokines and natural killer (NK) cells activity may also induce abortion. Various forms of treatment like antithrombotic therapies such as aspirin and heparin, intravenous immunoglobulin (IVIg) therapy, immunotherapy with paternal lymphocytes and vitamin D3 therapy are effective mode of treatment for unexplained cause of fetal loss in women with RSA. © Springer-Verlag 2005.
引用
收藏
页码:95 / 108
页数:13
相关论文
共 165 条
  • [1] Acien P., Reproductive performance of women with uterine malformations, Hum Reprod, 8, pp. 122-126, (1993)
  • [2] Acien P., Uterine anomalies and recurrent miscarriage, Infert Reprod Med Clin N Am, 7, pp. 689-719, (1996)
  • [3] Adachi H., Takakuwa K., Mitsui T., Ishii K., Tamura M., Tanaka K., Results of immunotherapy for patients with unexplained secondary abortions, Clin Immunol, 106, pp. 175-180, (2003)
  • [4] Agrawal S., Pandey M.K., The potential role of HLA-G polymorphism in maternal tolerance to the developing fetus, J Hematother Stem Cell Res, 12, pp. 749-756, (2003)
  • [5] Agrawal S., Pandey M.K., Mandal S., Mishra L., Agarwal S., Humoral immune response to an allogenic foetus in normal fertile women and recurrent aborters, BMC Pregnancy and Childbirth, 2, 1, (2002)
  • [6] Agrawal S., Pandey M.K., Pandey A., Prevalence of MLR blocking antibodies before and after immunotherapy, J Hematother Stem Cell Res, 9, pp. 257-262, (2000)
  • [7] Aldrich C.L., Stephenson M.D., Karrison T., Odem R.R., Branch D.W., Scott J.R., Schreiber J.R., Ober C., HLA-G genotypes and pregnancy outcome in couples with unexplained recurrent miscarriage, Mol Hum Reprod, 7, 12, pp. 1167-1172, (2001)
  • [8] Management of recurrent early pregnancy loss, ACOG Practice Bulletin, (2001)
  • [9] Anwar R., Gallivan L., Edmonds S.D., Markham A.F., Genotype/phenotype correlations for coagulation factor XIII: Specific normal polymorphisms are associated with high or low factor XIII specific activity, Blood, 93, pp. 897-905, (1999)
  • [10] Aoki K., Kajiura S., Matsumoto Y., Ogasawara M., Okada S., Yagami Y., Gleicher N., Preconceptional natural-killer-cell activity as a predictor of miscarriage, Lancet, 345, 8961, pp. 1340-1342, (1995)